Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-kbvt8 Total loading time: 0.521 Render date: 2021-10-22T02:46:46.262Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

20 - Myomectomy

from Section 3 - Infertility

Published online by Cambridge University Press:  01 February 2018

Elaine H. Stickrath
Affiliation:
Denver Health Medical Center, Denver CO, USA
Lisa Keder
Affiliation:
Ohio State University
Martin E. Olsen
Affiliation:
East Tennessee State University
Get access

Summary

Introduction

Uterine fibroids (myomas) affect nearly 80 percent of women. Risk factors for myomas include increasing age up to menopause and black race. Although not all myomas are symptomatic, many women suffer from pain, pressure symptoms, infertility, recurrent miscarriage, and abnormal uterine bleeding. Although many patients choose to undergo hysterectomy as definitive treatment for fibroids, others opt for myomectomy to preserve the uterus and fertility options. Myomas can be submucosal, intramural, or subserosal. Further classification into a numeric system 0–8 has been proposed to standardize the description of fibroid location. See Table 20.1 for specific details.

Myomectomy can be performed hysteroscopically, laparoscopically, or through a laparotomy. The indications for performing a myomectomy, how to approach the surgery, ways to optimize safety of the operation, and the risk of fibroid recurrence will be reviewed in this chapter.

Scope of the Problem

Fibroids can affect fertility in several ways. Depending on their location, they can lead to infertility, subfertility, or recurrent pregnancy loss. A meta-analysis looking at the affect of fibroids on fertility reported that women with myomas had lower pregnancy rates, less successful pregnancy implantations, and lower rates of live birth compared to infertile women with no myomas. The data analyzed in this study also showed that women with fibroids had higher spontaneous abortion rates. The authors then looked into the location of the myomas to determine which type of fibroids have the greatest impact on fertility. The meta-analysis showed that women with cavity distorting fibroids had lower rates of implantation, ongoing pregnancy and live-birth, and higher rates of spontaneous abortion compared to infertile women without myomas. The authors then looked into the effect of noncavity distorting myomas on fertility. The analysis of those women with intramural myomas showed the same negative impact on fertility as seen in women with cavity distorting fibroids. However, those women with subserosal myomas alone had no difference in any measure compared to infertile women without fibroids.

Benefits of Myomectomy

On the basis of this evidence, it would seem reasonable to offer women myomectomy for fertility improvement if their fibroids are either submucosal or intramural; the data, however, is limited and shows mixed results. A recent Cochrane Review on fertility improvement with hysteroscopic interventions found only two randomized controlled trials looking at hysteroscopic myomectomy compared with no intervention in subfertile women with submucosal myomas in situ.

Type
Chapter
Information
Gynecologic Care
, pp. 191 - 198
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baird, D, Dunson, D, Hill, M, Cousins, D, Schectman, J. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100–107.Google ScholarPubMed
2. Munro, M, Critchley, H, Broder, M et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 2011;113:3–13.CrossRefGoogle ScholarPubMed
3. Pritts, E, Parker, W, Olive, D. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91(4):1215–23.CrossRefGoogle Scholar
4. Bosteels, J, Kasius, J, Weyers, S et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2015;(2):CD009461.Google Scholar
5. Buttram, V, Reiter, R. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36(4):433.Google ScholarPubMed
6. Vilos, G, Allaire, C, Laberge, P et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–78.CrossRefGoogle ScholarPubMed
7. Klatsky, P, Tran, N, Caughey, A et al. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008;198(4):357–66.CrossRefGoogle ScholarPubMed
8. Chen, Y, Lin, H, Chen, S et al. Increased risk of preterm births among women with uterine leiomyoma: a nationwide population-based study. Hum Reprod 2009;24(12):3049–56.CrossRefGoogle ScholarPubMed
9. Stout, M, Odibo, A, Graseck, A et al. Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol 2010;116(5):1056–63.CrossRefGoogle ScholarPubMed
10. Hulka, J, Peterson, H, Phillips, J et al. Operative hysteroscopy: American Association of Gynecologic Laparoscopists’ 1993 membership survey. J Am Assoc Gynecol Laparosc 1995;2(2):131–2.Google Scholar
11. Ferrero, S, Racca, A, Tafi, E et al. Ulipristal acetate prior to high complexity hysteroscopic myomectomy: a retrospective comparative study. J Minim Invasive Gynecol 2015. [Epub ahead of print]Google Scholar
12. Pundir, J, Pundir, V, Walavalkar, R et al. Robotic-assisted laparoscopic vs. abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol 2013;20(3):335–45.CrossRefGoogle ScholarPubMed
13. Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication, Available at: www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm. Retrieved February 29, 2016.
14. Barron, K, Richard, T, Robinson, P et al. Association of the U.S. Food and Drug Administration morcellation warning with rates of minimally invasive hysterectomy and myomectomy. Obstet Gynecol 2015;126(6):1174–80.CrossRefGoogle Scholar
15. Chittawar, B, Franik, S, Pouwer, A et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids (review). Cochrane Database Syst Rev 2014;(10):CD004638.Google Scholar
16. LaMorte, A, Lalwani, S, Diamond, M. Morbidity associated with abdominal myomectomy. Obstet Gynecol 1993;82(6):897–900.Google ScholarPubMed
17. Lethaby, A, Vollenhoven, B, Sowter, M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001;(2):CD000547 Google Scholar
18. Conforti, A, Mollo, A, Alviggi, C, et al. Techniques to reduce blood loss during open myomectomy: a qualitative review of literature. Eur J Obstet Gynecol Reprod Biol 2015;192:90–5.CrossRefGoogle ScholarPubMed
19. Al-Shabibi, N, Chapman, L, Madari, S et al. Prospective randomized trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. Br J Obstet Gynaecol 2009;116(5):681–7.CrossRefGoogle ScholarPubMed
20. Frederick, J, Fletcher, H, Simeon, D et al. Intramyometrial vasopressin as a hemostatic agent during myomectomy. Br J Obstet Gynaecol 1994;101(5):1103–5.CrossRefGoogle ScholarPubMed
21. Fletcher, H, Frederick, J, Hardie, M et al. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996;87(6):1014–18.CrossRefGoogle ScholarPubMed
22. Wong, A, Cheung, C, Yeung, S et al. Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: a randomized controlled trial. Obstet Gynecol 2014;124(5):897–903.CrossRefGoogle ScholarPubMed
23. Celik, H, Sapmaz, E. Use of single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 2003;79(5);1207–10.CrossRefGoogle ScholarPubMed
24. Abdel-Hafeez, M, Elnaggar, A, Ali, M et al. Rectal misoprostol for myomectomy: a randomized placebo-controlled study. Aust N Z J Obstet Gynaecol 2015;55(4):363–8.CrossRefGoogle Scholar
25. Ragab, A, Khaiary, M, Badawy, A. The use of single versus double dose of intra-vaginal prostaglandin e2 “misoprostol” prior to abdominal myomectomy: a randomized controlled clinical trial. J Reprod Infertil 2014;15(3):152–6.Google ScholarPubMed
26. Shaaban, M, Ahmed, M, Farhan, R et al. Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas: a randomized controlled clinical trail. Reprod Sci 2015. [Epub ahead of print]Google Scholar
27. Ahmad, G, O'Flynn, H, Hindocha, A, Watson, A. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2015 (4):CD000475.Google Scholar
28. Tulandi, T, Closon, F, Czuzoj-Shulman, N, Abenhaim, H. Adhesion barrier use after myomectomy and hysterectomy: rates and immediate postoperative complications. Obstet Gynecol 2016;127(1):23–8.CrossRefGoogle ScholarPubMed
29. Malone, L. Myomectomy: recurrence after removal of solitary and multiple myomas. Obstet Gynecol 1969;34:200–203.Google ScholarPubMed
30. Martin-Merino, E, Rodriguez, L, Wallander, M et al. The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2015;194:147–52.CrossRefGoogle ScholarPubMed
31. Radosa, M, Owsianowski, Z, Mothes, A et al. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol 2014;180:35–9.CrossRefGoogle ScholarPubMed
32. Weibel, H, Jarcevic, R, Gagnon, R, Tulandi, T. Perspectives of obstetricians on labour and delivery after abdominal or laparoscopic myomectomy. J Obstet Gynaecol Can 2014;36(2):128–32.CrossRefGoogle ScholarPubMed
33. ACOG Committee Opinion #560. Medically indicated late-preterm and early-term deliveries. The American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Obstet Gynecol 2013;121(4):908–10.
34. Gambacorti-Passerini, Z, Gimovsky, A, Locatelli, A, Berghella, V. Trial of labor after myomectomy and uterine rupture: a systematic review. Acta Obstet Gynecol Scand 2016; [Epub ahead of print].Google Scholar

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Myomectomy
  • Edited by Lisa Keder, Ohio State University, Martin E. Olsen, East Tennessee State University
  • Book: Gynecologic Care
  • Online publication: 01 February 2018
  • Chapter DOI: https://doi.org/10.1017/9781108178594.021
Available formats No formats are currently available for this content.
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

  • Myomectomy
  • Edited by Lisa Keder, Ohio State University, Martin E. Olsen, East Tennessee State University
  • Book: Gynecologic Care
  • Online publication: 01 February 2018
  • Chapter DOI: https://doi.org/10.1017/9781108178594.021
Available formats No formats are currently available for this content.
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

  • Myomectomy
  • Edited by Lisa Keder, Ohio State University, Martin E. Olsen, East Tennessee State University
  • Book: Gynecologic Care
  • Online publication: 01 February 2018
  • Chapter DOI: https://doi.org/10.1017/9781108178594.021
Available formats No formats are currently available for this content.
×